Last updated: May 27, 2022
Sponsor: University of Salamanca
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT05401955
Interventional
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Allogenic Transplantation patients with Graft versus host disease
Exclusion
Exclusion Criteria:
- Cognitive impairment
- Physical limitation from other pathologies
Study Design
Total Participants: 12
Study Start date:
May 01, 2022
Estimated Completion Date:
July 30, 2023
Connect with a study center
University of Salamanca
Salamanca, 37007
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.